Novavax

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novavax and other ETFs, options, and stocks.

About NVAX

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. 

CEO
John C.s Jacobs
CEOJohn C.s Jacobs
Employees
952
Employees952
Headquarters
Gaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded
1987
Founded1987
Employees
952
Employees952

NVAX Key Statistics

Market cap
1.03B
Market cap1.03B
Price-Earnings ratio
-4.85
Price-Earnings ratio-4.85
Dividend yield
Dividend yield
Average volume
6.62M
Average volume6.62M
High today
$6.89
High today$6.89
Low today
$6.39
Low today$6.39
Open price
$6.61
Open price$6.61
Volume
5.08M
Volume5.08M
52 Week high
$23.86
52 Week high$23.86
52 Week low
$4.25
52 Week low$4.25

NVAX News

Benzinga 1d
Trump-Era FDA Appointees Request New Trials For Novavax COVID Vaccine, Reportedly Delaying Approval Timeline

The President Donald Trump administration’s request for Novavax Inc. NVAX to conduct new clinical trials for its COVID-19 vaccine. What Happened: Novavax annou...

Trump-Era FDA Appointees Request New Trials For Novavax COVID Vaccine, Reportedly Delaying Approval Timeline
TipRanks 2d
Novavax board ‘appreciates support of Shah Capital’

The company states: “Through constructive engagement with Shah Capital, a holder of approximately 7% of Novavax (NVAX) shares and who has pledged support for ou...

Benzinga 4d
Benzinga Bulls And Bears: Netflix, Novavax, Intel — And The Market Begins To Bounce Back

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. U.S. markets rebounded this...

Benzinga Bulls And Bears: Netflix, Novavax, Intel — And The Market Begins To Bounce Back

Analyst ratings

57%

of 7 ratings
Buy
57.1%
Hold
28.6%
Sell
14.3%

More NVAX News

Seeking Alpha 5d
Novavax told by FDA to conduct additional study for COVID vaccine - report

The U.S. FDA is asking Novavax (NASDAQ:NVAX) to conduct an additional randomized, controlled study of its COVID-19 vaccine before it will consider approving it....

Novavax told by FDA to conduct additional study for COVID vaccine - report
TipRanks 5d
Novavax asked for new Covid-19 vaccine trial by FDA, WSJ reports

Federal regulators have asked Novavax (NVAX) to conduct another randomized clinical trial of its Covid-19 vaccine following earlier delays in approval, Liz Essl...

Simply Wall St 5d
Novavax (NasdaqGS:NVAX) Announces Positive SHIELD-Utah Study Results

recently announced preliminary results from its SHIELD-Utah study, showcasing the Novavax COVID-19 vaccine's effectiveness and reduced side effects compared to...

Novavax (NasdaqGS:NVAX) Announces Positive SHIELD-Utah Study Results
Benzinga 7d
Novavax's COVID-19 Vaccine Nears FDA Full Approval, Stock Jumps

Novavax, Inc. NAVX stock traded higher on Wednesday. In an SEC filing, Novavax said, “We believe that our Biologics License Application (BLA) is approvable bas...

Novavax's COVID-19 Vaccine Nears FDA Full Approval, Stock Jumps
TipRanks 7d
Novavax has improved clarity on path forward for Nuvaxovid, says BofA

BofA notes that Novavax (NVAX) shares are up 21% after announcing the company has received communication from the FDA for a post marketing commitment to generat...

People also own

Based on the portfolios of people who own NVAX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.